Essential thrombocythemia is associated with increased risks of bleeding and thrombosis. Estimation of the risk of thrombosis is based on history of thrombosis, presence of the JAK2 V617F mutation, age, and cardiovascular risk. Treatment commonly involves low-dose aspirin; therapy is used in patients with high thrombotic risk.
PDF的下载单位、IP信息已删除
(2025-6-4)
辛勤冬天
GingerF
贪玩的秋柔
学术文献互助
1111
Willa
HFH
LiuZfosu
AllRightReserved
Dsivan
YifanWang
无极微光
MchemG
Jiaxin
邓佳鑫Alan
OK
Hayat
李伟
MP
Rita
皖公网安备34019202002308
